Stephen D Lawn1, Gavin Churchyard. 1. The Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, Anzio Road, Observatory 7925, Cape Town, South Africa. stevelawn@yahoo.co.uk
Abstract
PURPOSE OF REVIEW: We review literature concerning the epidemiology of HIV-associated tuberculosis (HIV-TB), focusing on articles published between 2007 and 2008. RECENT FINDINGS: An estimated 1.37 million new cases of HIV-TB occurred in 2007, representing 15% of the total global burden of TB. In addition, an estimated 456 000 HIV-TB deaths accounted for 23% of global HIV/AIDS mortality. Sub-Saharan Africa is the worst affected region with 79% of the disease burden. The epicentre of the coepidemic lies in the south of the continent, with South Africa alone accounting for over one quarter of all cases. A critical overlap between HIV and the global multidrug-resistant TB epidemics is emerging. Although it is as yet unclear whether HIV is driving a disproportionate increase in multidrug-resistant TB cases at a population level, HIV has nevertheless been a potent risk factor for institutional outbreaks, especially in South Africa and eastern Europe. Increasing data have highlighted the risk of TB among HIV-infected healthcare workers in resource-limited settings. However, many studies also show the major benefits to be derived from antiretroviral therapy in high-income and low-income countries. SUMMARY: HIV-TB remains a major challenge to global health that requires substantial increases in resource allocation and concerted international action.
PURPOSE OF REVIEW: We review literature concerning the epidemiology of HIV-associated tuberculosis (HIV-TB), focusing on articles published between 2007 and 2008. RECENT FINDINGS: An estimated 1.37 million new cases of HIV-TB occurred in 2007, representing 15% of the total global burden of TB. In addition, an estimated 456 000 HIV-TB deaths accounted for 23% of global HIV/AIDS mortality. Sub-Saharan Africa is the worst affected region with 79% of the disease burden. The epicentre of the coepidemic lies in the south of the continent, with South Africa alone accounting for over one quarter of all cases. A critical overlap between HIV and the global multidrug-resistant TB epidemics is emerging. Although it is as yet unclear whether HIV is driving a disproportionate increase in multidrug-resistant TB cases at a population level, HIV has nevertheless been a potent risk factor for institutional outbreaks, especially in South Africa and eastern Europe. Increasing data have highlighted the risk of TB among HIV-infected healthcare workers in resource-limited settings. However, many studies also show the major benefits to be derived from antiretroviral therapy in high-income and low-income countries. SUMMARY:HIV-TB remains a major challenge to global health that requires substantial increases in resource allocation and concerted international action.
Authors: C-N Bong; S C C Chen; Y-J Jong; T-S Tok; C-F Hsu; E J Schouten; S D Makombe; J K-L Yu; A D Harries Journal: Int J Tuberc Lung Dis Date: 2007-05 Impact factor: 2.373
Authors: Payam Nahid; Leah C Gonzalez; Irina Rudoy; Bouke C de Jong; Alon Unger; L Masae Kawamura; Dennis H Osmond; Philip C Hopewell; Charles L Daley Journal: Am J Respir Crit Care Med Date: 2007-02-08 Impact factor: 21.405
Authors: Daniel Westreich; Patrick MacPhail; Annelies Van Rie; Babatyi Malope-Kgokong; Prudence Ive; Dennis Rubel; Ronan Boulmé; Joseph Eron; Ian Sanne Journal: AIDS Date: 2009-03-27 Impact factor: 4.177
Authors: A Roderick Escombe; Clarissa Oeser; Robert H Gilman; Marcos Navincopa; Eduardo Ticona; Carlos Martínez; Luz Caviedes; Patricia Sheen; Armando Gonzalez; Catherine Noakes; David A J Moore; Jon S Friedland; Carlton A Evans Journal: Clin Infect Dis Date: 2007-04-09 Impact factor: 9.079
Authors: Hugo López-Gatell; Stephen R Cole; Joseph B Margolick; Mallory D Witt; Jeremy Martinson; John P Phair; Lisa P Jacobson Journal: AIDS Date: 2008-09-12 Impact factor: 4.177
Authors: Antonio G Pacheco; Betina Durovni; Solange C Cavalcante; L M Lauria; Richard D Moore; Lawrence H Moulton; Richard E Chaisson; Jonathan E Golub Journal: PLoS One Date: 2008-09-10 Impact factor: 3.240
Authors: Salome Charalambous; Alison D Grant; Craig Innes; Christopher J Hoffmann; Rob Dowdeswell; Jan Pienaar; Katherine L Fielding; Gavin J Churchyard Journal: AIDS Date: 2010-11 Impact factor: 4.177
Authors: S D Lawn; A D Harries; B G Williams; R E Chaisson; E Losina; K M De Cock; R Wood Journal: Int J Tuberc Lung Dis Date: 2011-05 Impact factor: 2.373